Literature DB >> 8443525

Serotonin syndrome caused by a moclobemide-clomipramine interaction.

O Spigset1, T Mjörndal, O Lövheim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8443525      PMCID： PMC1676747          DOI： 10.1136/bmj.306.6872.248

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

Review 1.  Neuroleptic malignant syndrome. When levodopa withdrawal is the cause.

Authors:  C Rainer; N A Scheinost; E J Lefeber
Journal:  Postgrad Med       Date:  1991-04       Impact factor: 3.840

Review 2.  The serotonin syndrome.

Authors:  H Sternbach
Journal:  Am J Psychiatry       Date:  1991-06       Impact factor: 18.112

Review 3.  Clinical pharmacokinetics of clomipramine.

Authors:  A E Balant-Gorgia; M Gex-Fabry; L P Balant
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447
  3 in total
  10 in total

Review 1.  Serotonin syndrome and drug combinations: focus on MAOI and RIMA.

Authors:  S E Hilton; H Maradit; H J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

Review 2.  Clinically significant drug interactions with antidepressants in the elderly.

Authors:  Edoardo Spina; Maria Gabriella Scordo
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 3.  Genetically determined adverse drug reactions involving metabolism.

Authors:  M S Lennard
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

Review 4.  Monoamine oxidase inhibitors. An update on drug interactions.

Authors:  M G Livingston; H M Livingston
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

5.  Serotonin syndrome caused by overdose with paroxetine and moclobemide.

Authors:  C R FitzSimmons; S Metha
Journal:  J Accid Emerg Med       Date:  1999-07

Review 6.  Drug interactions of clinical significance with selective serotonin reuptake inhibitors.

Authors:  P B Mitchell
Journal:  Drug Saf       Date:  1997-12       Impact factor: 5.606

Review 7.  The serotonin syndrome. Implicated drugs, pathophysiology and management.

Authors:  K A Sporer
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

8.  Concurrent use of more than one major psychotropic drug (polypsychopharmacy) in out-patients--a prescription database study.

Authors:  J U Rosholm; J Hallas; L F Gram
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

Review 9.  Comparative tolerability profiles of the newer versus older antidepressants.

Authors:  M V Rudorfer; H K Manji; W Z Potter
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

Review 10.  A risk-benefit assessment of moclobemide in the treatment of depressive disorders.

Authors:  T R Norman; G D Burrows
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.